Journal
NATURE IMMUNOLOGY
Volume 7, Issue 2, Pages 199-206Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ni1283
Keywords
-
Categories
Funding
- NIAID NIH HHS [AI050143, R01 AI050143] Funding Source: Medline
- NIGMS NIH HHS [GM25042] Funding Source: Medline
Ask authors/readers for more resources
CD22 is a negative regulator of B cell signaling, an activity modulated by its interaction with glycan ligands containing alpha 2-6-linked sialic acids. B cells deficient in the enzyme (ST6Gal 1) that forms the CD22 ligand show suppressed BCR signaling. Here we report that mice deficient in both CD22 and its ligand (Cd22(-/-) St6gal1(-/-) mice) showed restored B cell receptor ( BCR) signaling, suggesting that the suppressed signaling of St6gal1(-/-) cells is mediated through CD22. Coincident with suppressed BCR signaling, B cells lacking ST6Gal I showed a net redistribution of the BCR to clathrin-rich microdomains containing most of the CD22, resulting in a twofold increase in the localization of CD22 together with the BCR. These studies suggest an important function for the CD22-ligand interaction in regulating BCR signaling and microdomain localization.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available